Get an alert when PARAGON BIOMEDICAL LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-09-26 (in 4mo)

Last made up 2025-09-12

Watchouts

None on the register

Cash

£286K

-61.8% vs 2023

Net assets

£6M

+12% vs 2023

Employees

295

+4.2% vs 2023

Profit before tax

£893K

+63.1% vs 2023

Name history

Renamed 1 time since incorporation

  1. PARAGON BIOMEDICAL LIMITED 2005-06-27 → present
  2. INDATUM LIMITED 2003-09-12 → 2005-06-27

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £11,921,273£12,592,910
Operating profit £555,335£904,560
Profit before tax £547,568£893,270
Net profit £390,219£629,366
Cash £748,663£286,212
Total assets less current liabilities £5,412,421£6,064,721
Net assets £5,236,842£5,866,208
Equity £5,236,842£5,866,208
Average employees 283295
Wages £7,876,626£8,471,168

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 4.7%7.2%
Net margin 3.3%5.0%
Return on capital employed 10.3%14.9%
Current ratio 3.33x4.79x
Interest cover 71.50x80.12x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
Blick Rothenberg Audit LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Based on the cash position of the wider group and the forecast for 2025 and 2026, the Directors have full confidence that the ultimate parent company can provide the necessary financial support and therefore consider that it is appropriate for these financial statements to be prepared on the going concern basis.”

Group structure

  1. PARAGON BIOMEDICAL LIMITED · parent
    1. Clinipace Clinical Research Private Limited 100% · India · provision of a shared service function to the Caidya group

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 19 resigned

Name Role Appointed Born Nationality
CSC CLS (UK) LIMITED Corporate Secretary 2026-01-07
BROWN, Simone Director 2022-07-12 Sep 1973 British
RIFKIND, David Director 2022-07-12 Apr 1963 American
Show 19 resigned officers
Name Role Appointed Resigned
PORTER, Christopher Secretary 2012-09-25 2014-02-07
REED, Gena, Ms. Secretary 2005-05-27 2012-09-04
YOUNG, Tina Secretary 2003-09-12 2005-05-27
CANUTE SECRETARIES LIMITED Corporate Secretary 2012-09-27 2013-01-24
CF CLIENT SECRETARY LTD Corporate Secretary 2003-09-12 2003-09-12
BRITTON, Simon John Director 2021-10-01 2024-06-30
FRENKEL, Ran Director 2014-02-07 2015-12-11
HONEYCUTT, Parker Director 2017-07-17 2021-10-01
MONTELEONE, Jason Anthony, Mr. Director 2017-10-16 2022-07-12
PORTER, Christopher Director 2012-09-04 2017-04-13
REED, Gena, Ms. Director 2005-05-27 2012-09-04
REED, Nicholas, Mr. Director 2005-05-27 2012-07-19
SADANANDAN, Sibash Director 2003-09-12 2005-05-27
SCARBORO, Ronald Lee Director 2017-04-13 2017-07-17
TURNER, Karen, Mrs. Director 2017-12-21 2022-07-12
UBERT, Mark A. Director 2014-02-07 2016-09-30
WILLIAMS, Jeffrey Lewis Director 2012-09-04 2017-10-16
YOUNG, Tina Director 2003-09-12 2005-05-27
CF CLIENT DIRECTOR LTD Corporate Director 2003-09-12 2003-09-12

Ownership

Persons with significant control

No persons with significant control on record.

Filing timeline

Last 20 of 122 total filings

Date Type Category Description
2026-01-30 CH01 officers Change person director company with change date PDF
2026-01-30 CH01 officers Change person director company with change date PDF
2026-01-26 AP04 officers Appoint corporate secretary company with name date PDF
2026-01-26 AD01 address Change registered office address company with date old address new address PDF
2026-01-04 AA accounts Accounts with accounts type group
2025-09-30 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-02-07 AA accounts Accounts with accounts type group
2024-09-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-03 TM01 officers Termination director company with name termination date PDF
2024-01-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-11 AA accounts Accounts with accounts type small
2023-04-15 AA accounts Accounts with accounts type small
2023-03-14 DISS40 gazette Gazette filings brought up to date
2023-02-28 GAZ1 gazette Gazette notice compulsory
2022-09-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-07-12 AP01 officers Appoint person director company with name date PDF
2022-07-12 AP01 officers Appoint person director company with name date PDF
2022-07-12 TM01 officers Termination director company with name termination date PDF
2022-07-12 TM01 officers Termination director company with name termination date PDF
2021-11-08 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
6

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page